Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
Links shared publicly online about this topic.
- 1,585total visits
Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
fda.gov —
View full resource at fda.gov
Tags: Heart, Heart Disease, Heart Attack, Advanced Life Support, Stroke, Thrombotic Event, Drug, FDA
Most Recently Shared on November 21, 2009 at 11:02 pm By:
FDA issues Sat. night safety alert: Prelimnary data link weight-loss drug Meridia to higher risk of cardiovascular events http://tr.im/Fsxr
Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review
fda.gov — “Contraindication to use in patients with history of cardiovascular disease.” View full resource at fda.gov
Most Recently Shared on January 22, 2010 at 12:08 am By:
RT @ChrisHartman: Meridia (sibutramine hydrochloride): Follow-Up to Early Communication about an Ongoing Safety Review http://bit.ly/7eLaSn
FDA Alert: Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review
drugs.com — “FDA Alert: Meridia (sibutramine hydrochloride): Follow-Up to an Early Communication about an Ongoing Safety Review” View full resource at drugs.com
Most Recently Shared on January 21, 2010 at 10:44 pm By:
FDA Alert - New Cardiovascular Warnings for Meridia (sibutramine hydrochloride) - http://bit.ly/61YsM8
Follow-Up to the November 2009 Early Communication about an Ongoing Safety Review of Sibutramine, Marketed as Meridia
fda.gov — “The u.s. food and drug administration (fda) has reviewed additional data that indicate an increased risk of heart attack and stroke in patients with a history of cardiovascular disease using sibutramine, marketed as the weight loss medication meridia.” View full resource at fda.gov
Most Recently Shared on January 21, 2010 at 6:37 pm By:
UK bans Meridia, rest of Europe might http://bit.ly/7Wj5yl Meanwhile, FDA adds new contraindication to the diet pill http://bit.ly/4A070g
FDA Alert: Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review
drugs.com — “FDA Alert: Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review” View full resource at drugs.com
Most Recently Shared on November 23, 2009 at 8:01 am By:
FDA Alert - Meridia (sibutramine hydrochloride): Early Communication about an Ongoing Safety Review - http://bit.ly/6dolKX
Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride)
fda.gov — “FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo (sugar pill).” View full resource at fda.gov
Most Recently Shared on November 20, 2009 at 10:59 pm By:
Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride) (FDA) http://tinyurl.com/yao2rsg
Advertisement
